Dr. Anand Karnad received his medical degree from Madras Medical College at the University of Madras (Chennai), in India. Dr. Karnad is Chief, Division of Hematology-Oncology at the Department of Medicine, and the Cancer Therapy & Research Center (CTRC) and has been Professor of Medicine here since 2004. He has been an active investigator for the National Cancer Institute Clinical Trials for two decades, including trials designed to prevent and treat a range of cancers. He is principal investigator for the National Clinical Trials System (NCTN) SWOG trials at the CTRC. He is Program Director of the Hematology-Oncology Fellowship Training Program and has trained fellows since 1989. His clinical research interests include sarcoma, hematological disorders, and geriatric hematology-oncology. He holds the Castella endowed chair in aging. His career goal is to improve the care of patients with blood disorders and cancer through accelerating the completion of clinical trials and in helping to train the next generation of hematologists and oncologists.
Parra, A., Karnad, A. B. & Thompson, I. M. Hispanic Accrual on Randomized Cancer Clinical Trials: A Call to Arms. J. Clin. Oncol. 20;32(18):1871-3 (2014). PMID: 24841978; PMCID: PMC4050202
Parsons, H. M., Lathrop, K. I., Schmidt, S., Mazo-Canola, M., Trevino-Jones, J., Speck, H. & Karnad, A. B. Breast Cancer Treatment Delays in a Majority Minority Community: Is There a Difference? J. Oncol. Pract. 11(2):e144-53 (2014). PMID: 25515722; PMCID: PMC4365298
Rowe, J., Patel, S., Mazo-Canola, M., Parra, A., Goros, M., Michalek, J., Kelly, K., Weitman, S. & Karnad, A. An evaluation of elderly patients (>/=70years old) enrolled in Phase I clinical trials at UT Health San Antonio-Cancer Therapy Research Center from 2009 to 2011. J. Geriatr. Oncol. 5, 65-70 (2014). PMID: 24484720; PMCID: PMC3914160